Red Nucleus ( “the Company”), a leading provider of strategic services across research and development, medical affairs, market access, and learning and development, announces that it has received a majority investment from THL Partners (“THL”), a premier private equity firm investing in middle market growth companies. The strategic partnership will help broaden the Company’s suite of commercialization services for its global customer base. Founded over 30 years ago, Red Nucleus claims a global team of 700 professionals across seven countries. Red Nucleus serves more than 200 organizations, including innovative biotech start-ups and the majority of the top 25 global pharmaceutical companies by market capitalization.
Read the full article: Red Nucleus Announces Majority Investment from THL Partners //
Source: https://www.businesswire.com/news/home/20241017041627/en/Red-Nucleus-Announces-Majority-Investment-from-THL-Partners